“showed a trend”

Nonetheless, incidence of Grade 3 diarrhea showed a trend towards improvement (odds ratio [OR] 0.61, 95% CI 0.35; 1.07, P = 0.26).

The pooled analysis suggested that eGFR only showed a trend to increase after conversion versus before conversion in renal transplant patients (MD (95% CI): 2.21 (−1.62, 6.03) mL/min/1.73 m 2 , p = 0.26) ( Figure 2B ) but without statistical significance. 3.4 Subgroup analysis for Scr and eGFR Subgroup analysis on Scr was conducted based on the follow-up duration.

In contrast, combination treatment with TACE + RFA showed a trend towards improved survival compared with no treatment (67.1% vs 63.3%, p=0.26, Figure 5 ) but did not reach statistical significance.

Sensory nerve action potential (SNAP) sum score also showed a trend to improvement, increasing from 11.7 microvolts (uv) to 15.7 uv at 2 years, ( P =0.26) ( Figure 2B ).

Similarly, none of the calculated indexes was affected by Dmab ( Table 2 ), though HOMA-IR and insulinogenic indexes showed a trend toward reduction (2.01 ± 1.52 versus 1.81 ± 1.05; p =0.27 and 0.78 ± 0.64 versus 0.64 ± 0.48; p =0.45, respectively), while Matsuda and QUICKI Indexes showed a nonsignificant trend to increase (5.79 ± 3.51 versus 7.64 ± 8.58; p =0.26 and 0.362 ± 0.043 versus 0.365 ± 0.042; p =0.51, respectively).

The findings also showed a trend toward fewer patients in the pre-RSB group not receiving first analgesics within 24 hours (67 vs 74 patients, P = .26).

Furthermore, GREB1 also showed a trend of overexpression in platinum sensitive samples, regardless of PARP level ( P = .26).

However, active SLE patients showed a trend of higher frequency of calcitriol serum levels in the third tertile ( T 3 rd = 50%) compared to inactive SLE patients ( p = 0.26) ( Table 1 ).

The unmatched analysis showed a trend toward higher 30- and 90-d mortality in the FFP group (30 d: +7% p = 0.261; 90 d: +11.9% p = 0.061).

OS was similar between active surveillance and surgery groups in both intent-to-treat and as-treated analyses, but DFS showed a trend favoring surgery (2-year DFS: 66.7% surgical vs. 42.7% surveillance; p=0.262).

Median PFS showed a trend of superiority in c-Met overexpression group (15.2 versus 11.0 months, P = 0.263).

CNS metastases Compared with patients with HER2-negative SGCs, the HER2-positive group showed a trend towards higher prevalence of CNS metastases: 40% ( 10 ) vs. 24% ( 9 ) (p=0.263).

We demonstrated that preincubation with SC-57461A, a selective inhibitor of LTA 4 H, increased the expression levels of E-cadherin compared to stimuli with LTB 4 (Kruskal-Wallis Test; P = 0.0103; Figures 5 A and B), however, 10 μM of ALA showed a trend towards increased expression of the epithelial marker (Kruskal-Wallis Test; P = 0.2633; Figures 5 A and B).

On the baseline ECG, the late responders showed a trend toward a lower prevalence of typical left bundle branch block (LBBB) (91.7% vs. 66.7% vs. 71.4%, in early, late and non-responders, respectively, p = 0.264) compared to early responders.

IHC analysis showed a trend towards worse PFS within the first year for patients with MCP-1 expression in tumor tissue (HR: 3.252, p = 0.264).

Although not statistically significant, trigone D50% also showed a trend toward higher doses in patients reporting late UD (16.7 Gy vs. 17.5 Gy, p = 0.265).

While overall survival analysis showed a trend toward poorer outcomes in the high-expression group, this difference did not reach statistical significance ( P = 0.265; Fig. 4 B).

The MET group showed a trend toward lower alcohol impact probability (median predicted probability 0.3 vs. 0.47 in the control group, p = 0.265), consistent with a proteomic signature associated with reduced heavy alcohol consumption ( Table 2 ; Supplementary Table S3 ).

The TIM‐3 positive group showed a trend toward poorer outcomes in terms of DSS ( p = 0.265), DFS ( p = 0.168), and RFS ( p = 0.059), without statistical significance (Figure 4 ).

IKKbeta pathway The results obtained by western blot showed a trend towards an increase of pIKKbeta levels in the cortex of WT mice exposed to HFD ( p = 0.267) ( Fig 4D and 4E ).

IVUS showed a trend toward a larger luminal area (6.86 ± 2.59 vs. 5.47 ± 1.52 mm 2 , p = 0.267), smaller neointimal area (1.34 ± 0.70 vs. 2.40 ± 1.73 mm 2 , p = 0.18), and reduced net decrease in luminal area (-0.78 ± 0.97 vs. -1.89 ± 1.78 mm 2 , p = 0.106) in the carvedilol stent group compared with the control stent group, respectively.

Although obese children with low muscle mass showed a trend toward higher cIMT compared to obese peers without low muscle mass (0.401 ± 0.020 mm vs. 0.389 ± 0.040 mm, p = 0.268; Cohen’s d = 0.328), this difference did not reach statistical significance, likely due to the limited sample size with available cIMT measurements ( n = 11 vs. n = 29).

The overall pooled analysis showed a trend toward clinical improvement that was not statistically significant (MD: 0.70; 95% CI: -0.55, 1.95; p = 0.2682).

In fact, this study showed a trend of increased anastomotic complications in patients who received carboplatin/paclitaxel (33% vs. 15%, p = 0.27) [17] .

Age showed a trend toward lower odds of forensic exam being offered with increasing age (AOR 0.96, 95% CI, 0.89–1.03, P = .27), although this did not reach statistical significance.